cjc-1295 + ipamorelin with dac dosage CJC 1295 Ipamorelin + CJC-1295: Peptide Combo
Description
Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-Tetarfolatide)
Cloyd, J
The study by Speiser et al
T.TaylorW
Mild vacuolated fibrocytes of the spiral ligament were detected (Fig
